ROBITUSSIN Trademark

Trademark Overview


On Monday, August 2, 2021, a trademark application was filed for ROBITUSSIN with the United States Patent and Trademark Office. The USPTO has given the ROBITUSSIN trademark a serial number of 90860680. The federal status of this trademark filing is REGISTERED as of Tuesday, December 27, 2022. This trademark is owned by GSK Consumer Healthcare SARL. The ROBITUSSIN trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements
robitussin

General Information


Serial Number90860680
Word MarkROBITUSSIN
Filing DateMonday, August 2, 2021
Status700 - REGISTERED
Status DateTuesday, December 27, 2022
Registration Number6933538
Registration DateTuesday, December 27, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2022

Trademark Statements


Goods and ServicesDietary and nutritional supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 28, 2021
Primary Code005
First Use Anywhere DateTuesday, June 30, 2020
First Use In Commerce DateTuesday, June 30, 2020

Trademark Owner History


Party NameHALEON US HOLDINGS LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWILMINGTON, DE 19808

Party NameGLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWILMINGTON, DE 19808

Party NameGLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWILMINGTON, DE 19808

Party NameGLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
Party Type12 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressWILMINGTON, DE 19808

Party NameGlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Party NameGSK Consumer Healthcare SARL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPrangins CH-1197
CH

Trademark Events


Event DateEvent Description
Wednesday, February 7, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 27, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 27, 2022REGISTERED-PRINCIPAL REGISTER
Monday, October 17, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 17, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 17, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 30, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, June 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 1, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, June 1, 2022FINAL REFUSAL E-MAILED
Wednesday, June 1, 2022FINAL REFUSAL WRITTEN
Wednesday, June 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 28, 2022ASSIGNED TO LIE
Monday, May 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 29, 2022NON-FINAL ACTION E-MAILED
Friday, April 29, 2022NON-FINAL ACTION WRITTEN
Friday, April 29, 2022ASSIGNED TO EXAMINER
Tuesday, September 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 5, 2021NEW APPLICATION ENTERED